CLINICAL_TRIALS ClinicalTrials.gov record update

Open Multicenter Prospective Observational Trial of the Efficacy and Safety of Use of Drug Product Reamberin® Solution for Infusion, 1.5 % (Scientific Technological Pharmaceutical Firm "POLYSAN") for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07066540
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:35.596553+00:00
Published At: 2025-07-15T00:00:00+00:00
Record Updated At: 2025-07-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Viral Enteric Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-15"
protocolSection.identificationModule.nctId: "NCT07066540"
protocolSection.identificationModule.officialTitle: "Open Multicenter Prospective Observational Trial of the Efficacy and Safety of Use of Drug Product Reamberin\u00ae Solution for Infusion, 1.5 % (Scientific Technological Pharmaceutical Firm \"POLYSAN\") for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.